通过蛋白质语言模型发现用于癌症免疫治疗的高活性kynureninases
Hyunuk Eom1, Sukhwan Park2, Kye Soo Cho3
1Department of Chemistry, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea.
Nucleic acids research
|January 8, 2025
概括
这项研究引入了一种使用蛋白质语言模型来发现和优先考虑治疗应用酶的新方法. 开发的方法成功地识别出一种强大的 kynureninase,在临床前模型中显著降低瘤重量.
科学领域:
- 生物技术是生物技术.
- 酶工程是什么? 酶工程是什么?
- 计算生物学 计算生物学
背景情况:
- 针对特定应用的酶发现具有挑战性,因为需要高通量选.
- kynureninases 水解L-kynurenine,这是一个涉及瘤免疫抑制的代谢物.
- 向免疫抑制瘤微环境是抗癌疗法的关键策略.
研究的目的:
- 开发和验证一种基于动力参数的计算方法来发现和优先考虑酶.
- 为了确定在克服瘤免疫抑制方面潜在的治疗用途的新型kynureninases.
- 在体外和体内实验评估计算选择的kynureninases的疗效.
主要方法:
- 采用同类学搜索和蛋白质语言模型来发现和优先考虑酶.
- 专注于鉴定kynureninases,因为它们具有解L-kynurenine的潜力.
- 实验验证了排名第一的 kynureninase 候选物的催化活性和体内疗效.
主要成果:
- 与现有的酶相比,确定了一种kinureninase,与现有的酶相比,其营业额几乎增加了两倍.
- 在接受选择酶治疗的小鼠模型中,瘤重量显著减少了3.4倍.
- 验证了计算工作流程在预测和选择有效酶方面的准确性.
结论:
- 开发的计算方法使得有针对性的,定量化的酶发现和选择具有高精度.
- 这种方法显著提高了酶利用范围,用于包括癌症治疗在内的各种应用.
- 这些发现为克服免疫抑制瘤微环境提供了一个有希望的策略.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K


